An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
White matter pathology has been documented in the brains of familial Alzheimer's disease (FAD)‐afflicted individuals during presymptomatic and preclinical stages of AD. How these defects in myelination integrity arise and what roles they may play in AD pathophysiology have yet to be fully elucidated. We previously demonstrated that triple‐transgenic AD (3xTg‐AD) mice, which harbor the human amyloid precursor Swedish mutation, presenilin‐1 M146V (PS1 M146V) knock‐in mutation, and tau P301L mutation, exhibit myelin abnormalities analogous to FAD patients and that Aβ 1‐42 contributes to these white matter deficits. Herein, we demonstrate that the PS1 M146V mutation predisposes mouse oligodendrocyte precursor (mOP) cells to Aβ 1‐42‐induced alterations in cell differentiation in vitro. Furthermore, PS1 M146V expression compromised mOP cell function and MBP protein distribution, a process that is further aggravated with exposure to Aβ 1‐42. We found that the myelination defect and MBP subcellular mislocalization triggered by PS1 M146V and Aβ 1‐42 can be effectively prevented by treatment with the GSK‐3β inhibitor, TWS119, thereby implicating GSK‐3β kinase activity in this pathogenic cascade. Overall, this work provides further mechanistic insights into PS1 M146V and Aβ 1‐42‐driven oligodendrocyte dysfunction andmyelin damage during early presymptomatic stages of AD, and provides a new target in oligodendrocytes for developing therapies designed to avert AD‐related white matter pathology. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 2×
“PS1 is the catalytic component of the multi-subunit gamma secretase complex, arguably best known for its role in amyloidogenic processing of APP to yield pathogenic Aβ peptide species (Scheuner et al. 1996).”
BackgroundBiology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 7×
“The 3xTg-AD mice express the hAPPswe and htauP301L transgenes exclusively in neurons, whereas the hPS1M146V knock-in mutation is expressed in neurons and glia, including oligodendrocytes (Oddo et al., 2003b).”
BackgroundMethodInfluentialMyelin basic protein: a multifunctional protein
Boggs, J. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6094-7 · Cited by 687
LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10369 · Cited by 388
A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging
Miller, J. A., Oldham, M. C., & Geschwind, D. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4098-07.2008 · Cited by 385
Ringman, J. M., O'Neill, J., Geschwind, D., Medina, L., Apostolova, L. G., Rodriguez, Y., Schaffer, B., Varpetian, A., Tseng, B., Ortiz, F., et al. (2007) · Brain · doi:10.1093/brain/awm102 · Cited by 290
Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279 · cited 2×
“White matter degeneration has been extensively reported in the brains of AD patients (Firbank et al. 2007; Hanyu et al. 1998; Roher et al. 2002).”
BackgroundSternberger, N. H., Itoyama, Y., Kies, M. W., & Webster, H. D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2521 · Cited by 270 · cited 2×
“Previously, heterogeneous MBP protein distribution patterns have been reported in the oligodendrocytes of adult mouse brains, where mature oligodendrocytes express MBP exclusively in myelin sheaths (Hardy et al., 1996; Sternberger et al., 1978a,b).”
BackgroundDesai, M. K., Sudol, K. L., Janelsins, M. C., Mastrangelo, M. A., Frazer, M. E., & Bowers, W. J. (2009) · Glia · doi:10.1002/glia.20734 · Cited by 266 · cited 9×
“, 2003a), which express the human presenilin-1 M146V mutation (hPS1), human amyloid precursor protein Swedish mutation (hAPP), and the human tau P301L mutation (htau), exhibit white matter deficits in comparable brain regions at ages prior to the appearance of overt amyloid and tau-related pathology (Desai et al., 200…”
BackgroundMethodResultInfluentialSelf-citation
Cited by
White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723
“Aβ and tau: Several studies suggest that Aβ is toxic to oligodendrocytes [28, 29, 41, 48, 84].”
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
Behrendt, G., Baer, K., Buffo, A., Curtis, M. A., Faull, R. L., Rees, M. I., Götz, M., & Dimou, L. (2013) · Glia · doi:10.1002/glia.22432 · Cited by 219
Microglia regulation of central nervous system myelin health and regeneration
Kent, S. A., & Miron, V. E. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00907-4 · Cited by 183
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & de la Fuente, A. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.572090 · Cited by 167
Metadata
- Authors
- Desai, M. K., Guercio, B. J., Narrow, W. C., & Bowers, W. J.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2011-02-03
- Volume
- 59
- Issue
- 4
- Pages
- 627-640
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1997151347
- Cited by
- 75
- References
- 16
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction. https://app.cochat.ai/papers/10.1002/glia.21131
- The paper
- Desai, M. K., Guercio, B. J., Narrow, W. C., & Bowers, W. J. (2011). An Alzheimer's disease‐relevant presenilin‐1 mutation augments amyloid‐beta‐induced oligodendrocyte dysfunction. Glia. https://doi.org/10.1002/glia.21131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.